Table 6.
Odds ratio (95% CI) | P‐value | |
---|---|---|
Age (< 75 vs. ≥ 75) | 3.440 (0.804–14.700) | 0.096 |
Smoking history (No vs. Yes) | 1.520 (0.317–7.290) | 0.601 |
BSA (≥ 1.5 vs. < 1.5) | 2.040 (0.427–9.710) | 0.372 |
CCr (mL/min)† or eGFR (mL/min/1.73 m2)‡ (≥60 vs. <60) | 0.487 (0.113–2.110) | 0.336 |
ECOG PS (0–1 vs. ≥ 2) | 2.230 (0.386–12.900) | 0.370 |
Treatment lines (second‐ vs. third−/later‐line) | 1.340 (0.313–5.770) | 0.691 |
CCr was calculated using the Cockcroft and Gault (CG) equation for glomerular filtration rate (GFR) estimation.
eGFR was determined using the Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) creatinine‐based equation.
BSA, body surface area; CCr, creatinine clearance; ECOG, Eastern Cooperative Oncology Group; eGFR, estimated glomerular filtration rate; PFS, progression‐free survival; PS, performance status.